These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25481644)

  • 1. Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer.
    Alshaker H; Wang Q; Frampton AE; Krell J; Waxman J; Winkler M; Stebbing J; Cooper C; Yagüe E; Pchejetski D
    Breast Cancer Res Treat; 2015 Jan; 149(1):59-67. PubMed ID: 25481644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway.
    Alshaker H; Krell J; Frampton AE; Waxman J; Blyuss O; Zaikin A; Winkler M; Stebbing J; Yagüe E; Pchejetski D
    Breast Cancer Res; 2014 Oct; 16(5):426. PubMed ID: 25482303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosine kinase 1 induces tolerance to human epidermal growth factor receptor 2 and prevents formation of a migratory phenotype in response to sphingosine 1-phosphate in estrogen receptor-positive breast cancer cells.
    Long JS; Edwards J; Watson C; Tovey S; Mair KM; Schiff R; Natarajan V; Pyne NJ; Pyne S
    Mol Cell Biol; 2010 Aug; 30(15):3827-41. PubMed ID: 20516217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Raloxifene inhibits pancreatic adenocarcinoma growth by interfering with ERβ and IL-6/gp130/STAT3 signaling.
    Pozios I; Seel NN; Hering NA; Hartmann L; Liu V; Camaj P; Müller MH; Lee LD; Bruns CJ; Kreis ME; Seeliger H
    Cell Oncol (Dordr); 2021 Feb; 44(1):167-177. PubMed ID: 32940862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
    Kim SH; Nagalingam A; Saxena NK; Singh SV; Sharma D
    Carcinogenesis; 2011 Mar; 32(3):359-67. PubMed ID: 21163886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas.
    Gao SP; Mark KG; Leslie K; Pao W; Motoi N; Gerald WL; Travis WD; Bornmann W; Veach D; Clarkson B; Bromberg JF
    J Clin Invest; 2007 Dec; 117(12):3846-56. PubMed ID: 18060032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of sphingosine 1-phosphate receptor 4 and sphingosine kinase 1 is associated with outcome in oestrogen receptor-negative breast cancer.
    Ohotski J; Long JS; Orange C; Elsberger B; Mallon E; Doughty J; Pyne S; Pyne NJ; Edwards J
    Br J Cancer; 2012 Apr; 106(8):1453-9. PubMed ID: 22460268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma.
    Zhuang PY; Wang JD; Tang ZH; Zhou XP; Quan ZW; Liu YB; Shen J
    BMC Cancer; 2015 Nov; 15():830. PubMed ID: 26525581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leptin stimulates interleukin-6 production via janus kinase 2/signal transducer and activator of transcription 3 in rheumatoid synovial fibroblasts.
    Muraoka S; Kusunoki N; Takahashi H; Tsuchiya K; Kawai S
    Clin Exp Rheumatol; 2013; 31(4):589-95. PubMed ID: 23622344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
    Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of IL-8 via PI3K/Akt-dependent pathway is involved in leptin-mediated epithelial-mesenchymal transition in human breast cancer cells.
    Wang L; Tang C; Cao H; Li K; Pang X; Zhong L; Dang W; Tang H; Huang Y; Wei L; Su M; Chen T
    Cancer Biol Ther; 2015; 16(8):1220-30. PubMed ID: 26121010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
    Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
    Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinhibition of S1PR1 and GP130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
    Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
    J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tunicamycin-induced ER stress regulates chemokine CCL5 expression and secretion via STAT3 followed by decreased transmigration of MCF-7 breast cancer cells.
    Zhang Y; Liao S; Fan W; Wei W; Wang C; Sun S
    Oncol Rep; 2014 Dec; 32(6):2769-76. PubMed ID: 25231320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin.
    Yin N; Wang D; Zhang H; Yi X; Sun X; Shi B; Wu H; Wu G; Wang X; Shang Y
    Cancer Res; 2004 Aug; 64(16):5870-5. PubMed ID: 15313931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bazedoxifene is a novel IL-6/GP130 inhibitor for treating triple-negative breast cancer.
    Tian J; Chen X; Fu S; Zhang R; Pan L; Cao Y; Wu X; Xiao H; Lin HJ; Lo HW; Zhang Y; Lin J
    Breast Cancer Res Treat; 2019 Jun; 175(3):553-566. PubMed ID: 30852762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin converting enzyme 2 alleviates infectious bronchitis virus-induced cellular inflammation by suppressing IL-6/JAK2/STAT3 signaling pathway].
    Ji X; Wang H; Ma C; Li Z; DU X; Zhang Y
    Sheng Wu Gong Cheng Xue Bao; 2023 Jul; 39(7):2669-2683. PubMed ID: 37584123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin-STAT3-G9a Signaling Promotes Obesity-Mediated Breast Cancer Progression.
    Chang CC; Wu MJ; Yang JY; Camarillo IG; Chang CJ
    Cancer Res; 2015 Jun; 75(11):2375-2386. PubMed ID: 25840984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer.
    Berishaj M; Gao SP; Ahmed S; Leslie K; Al-Ahmadie H; Gerald WL; Bornmann W; Bromberg JF
    Breast Cancer Res; 2007; 9(3):R32. PubMed ID: 17531096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components.
    Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.